An In Vitro Method for the Differentiation of Megakaryocytes and Platelet Formation

Published: July 31, 2023

Abstract

Source: Perdomo, J., et al. Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells. J. Vis. Exp. (2017)

This video demonstrates a technique for the differentiation of megakaryocytes and the formation of platelets. Hematopoietic stem progenitor cells — isolated from human umbilical cord blood — differentiate into mature megakaryocytes in the presence of thrombopoietin. The mature megakaryocytes produce cytoplasmic extensions termed proplatelets, which give rise to individual platelets.

Protocol

All procedures involving human participants have been performed in compliance with the institutional, national, and international guidelines for human welfare and have been reviewed by the local institutional review board.

1. Megakaryocyte Differentiation

  1. Seed 5 × 105 cells/mL CD34+ cells in 2 mL of SFM supplemented with 50 ng/mL recombinant human thrombopoietin (rhTPO) per well in a 12-well plate. Incubate cells at 37 °C, 5% CO2 in a humidified atmosphere. If cells are confluent before they are required for analysis, harvest the cells and split them into multiple wells with fresh media and rhTPO.
    NOTE: Two or three wells should be prepared specifically to monitor differentiation at different time points (e.g., days 7, 9, and 10).
  2. Harvest cells from the wells set aside to monitor differentiation without disturbing the cells in the other wells.
  3. Stain cells with 20 µL anti-GPIIb/CD41-FITC antibody and 10 µL anti-GPIX/CD42a-Alexa Fluor 647 antibody in a final volume of 100 µL. Set up a control tube using the respective isotype control antibodies. Incubate for 15 – 30 min at 4 °C.
  4. Add 1 mL of SB to wash. Centrifuge at 400 × g for 10 min. Discard the supernatant and resuspend the pellet in 200 – 300 µL of SB. Analyze by flow cytometry.
  5. For each fluorophore, analyze the isotype controls to set the gating for FITC and Alexa Flour 647 positive populations. Analyze the stained cell samples to determine the percent of CD41+/CD42a+ double positive cells, which represent mature MK (Figure 1C).
  6. For microscopic visualization of cell surface markers stain cells as described in 1.3.
    1. Add 1 mL of SB to wash. Centrifuge at 400 × g for 10 min. Resuspend the pellet in 100 µL of SB and spin onto a glass slide at 1,000 x g for 5 min. Fix cells on the slide by dipping them in methanol for 30 s. Air dry, add 20 µL of mounting media containing DAPI (see Table of Materials), cover with a coverslip, and visualize using a fluorescent microscope (Figure 2A).
  7. For visualization of intracellular antigens, resuspend cells in PBS and fix with paraformaldehyde (1% final concentration) for 15 min at room temperature. To permeabilize the cells, add triton-X 100 (0.1%) and incubate for 15 min. Wash cells with 2 mL PBS/0.1% triton-X 100. Resuspend in 100 µL of PBS/0.1% triton-X 100, add anti-vWf and anti-CD62p antibodies (1:200 dilution), and incubate for 30 min at room temperature.
    1. Wash with 2 mL PBS/0.1% triton-X 100 and centrifuge at 400 × g for 10 min, resuspend in 100 µL of the same buffer, and add anti-mouse IgG-Alexa 594 and anti-rabbit IgG-Alexa 488 (1:100). Incubate for 30 min at room temperature, wash with 2 mL PBS/0.1% triton-X 100, resuspend in 100 µL of the same buffer, and add 20 µL of anti-CD42b-APC. Then spin the cells onto glass slides as described in step 1.6.1 and prepare samples for microscopic visualization as described in step 1.6.1.
  8. For ploidy determination, harvest cells at days 12 or 13 of differentiation. Add 1 mL of SB to wash. Centrifuge at 400 × g for 10 min and stain with 20 µL anti-GPIIb/CD41-FITC antibody in a final volume of 100 µL. Incubate at 4 °C for 30 min.
    1. Wash once with 1 mL of SB and resuspend the pellet in 300 µL of hypotonic citrate buffer (1.25 mM sodium citrate, 2.5 mM sodium chloride, 3.5 mM dextrose) containing 20 µg/ml propidium iodide and 0.05% Triton-X 100. Incubate for 15 min at 4 °C protected from light.
    2. Add RNase to a final concentration of 20 µg/mL and incubate for 30 min at 4 °C protected from light. Determine the intensity of propidium iodide by flow cytometry by collecting 30,000 to 50,000 events of the CD41-FITC+ population (Figure 2C).

2. Proplatelet Counting, Platelet Enumeration, and Platelet Activation

  1. Harvest cells (from step 1.1) at days 8 or 9 of differentiation and seed at 1 × 104 cells/well in 48-well plates in 200 µL of fresh SFM supplemented with 50 ng/mL rhTPO. Culture for 5 days at 37 °C, 5% CO2.
    NOTE: For quantitation purposes, seed wells in triplicate. This low density is required for visualization and counting of proplatelet-bearing MK. Proplatelets usually start appearing after 2 days of culture. The peak is between days 4 and 5.
  2. Count the number of proplatelet-bearing MK in the whole well on an inverted light microscope using 10X or 20X objectives.
    NOTE: A heated (37 °C) microscope stage is preferable since keeping the cells at room temperature for extended periods causes shrinkage of the proplatelet extensions. Proplatelets are observed as long extensions from the MK body. Each MK may have several proplatelet protrusions. As proplatelets develop, the body of the MK decreases in size.
  3. Harvest cells and centrifuge at 400 x g for 10 min at room temperature. Stain cells with 20 µL anti-human CD41-FITC antibody, as described in steps 1.3 and 1.4. Calculate the percentage of proplatelet-bearing MK (pbMK):
    pbMK (%) = [(Proplatelet-bearing MKs/ well) / (Total CD41+ cells/ well)] x 100
  4. To count platelets released into the culture medium, gently mix the cells with a Pasteur pipette and collect 100 µL at days 14 or 15 of culture.
    1. Stain with 20 µL anti-human CD41-FITC antibody for 20 – 30 min at 4 °C. Set up a control tube using the respective isotype control antibody.
    2. Add 150 µL of SB and 50 µL of counting beads.
    3. For flow cytometric analysis, set the FSC and SSC to log scale. Use normal human blood platelets from platelet-rich plasma stained with CD41-FITC as described in section 2.4.1 to set the gating for platelets (Figure 3A).
    4. Analyze the stained platelets by counting beads by flow cytometry. Collect 1,000 events of counting beads using the FSC versus SSC scatter plot (Figure 3A). Calculate the number of platelets based on CD41-FITC positive events (Figure 3B) using the formula:
      Platelets per µL=[(number of CD41-FITC positive events)/1,000 beads)] x [(number of beads in 50 µL)/sample volume)]
  5. To analyze platelet activation, gently mix the cells with a Pasteur pipette and collect 100 µL at days 14 or 15 of culture. Add 1 mL of Tyrode's buffer (137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, 0.2 mM Na2HPO4, 12 mM NaHCO3, 5.5 mM D-glucose, pH 6.5) and centrifuge at 200 x g for 5 min to pellet cells.
    1. Collect the supernatant and centrifuge at 800 x g for 10 min to pellet platelet-sized particles.
    2. Discard the supernatant and resuspend in 100 µL of Tyrode's buffer. Add 20 µL of PAC1-FITC antibody and adenosine diphosphate (ADP) to a final concentration of 20 µM. Incubate at room temperature for 20 min. Analyze by flow cytometry to determine the percentage of FITC-positive events. Use fresh human platelets treated in the same manner as a positive control (Figure 3C).

Representative Results

Figure 1
Figure 1: Flow cytometry plots of CD34+ cell isolation and MK differentiation in culture. (A) Mononuclear cells (gated as shown in the left panel) purified from human cord blood were stained with anti-CD34-PE antibody to determine the percentage of the CD34+ cells in the sample (1.3%, right panel). (B) After separation, the positive fraction was stained with anti-CD34-PE and anti-CD45 PerCP antibodies. The enriched CD34+ population is indicated in the figure (98.1%, right panel, upper right quadrant). (C) Phenotypic analysis of MK differentiated in vitro from CD34+ cells for 7 days or 11 days were stained with anti-CD41 and anti-CD42a antibodies. Mature MKs are positive for both CD41+ and CD42a+ (upper right quadrant).

Figure 2
Figure 2: MK staining, ploidy, and proplatelet formation in vitro. (A) Fluorescent images of day 11 MK stained with anti-CD41-PE and CD42b-APC antibodies. Nuclei were stained with DAPI. Yellow arrowhead indicates multi-nuclear MKs. Scale bar, 30 µm. (B) Fluorescent images of day 14 MK stained with anti-vWf (green), anti-CD62p (red), and anti-CD42b-APC (magenta) antibodies. Nuclei were stained with DAPI. Scale bar, 15 µm (C) Representative gating strategy showing the ploidy distribution of CD41+ events. The graph (lower panel) shows the observed distribution of ploidy classes (n = 4), error bars, SD. (D) The characteristic morphology of proplatelet-bearing MK is shown. The MK body is indicated by the arrow. The long cytoplasmic processes extending from the MK (proplatelets) are indicated by arrowheads. It may be unclear in some areas/fields of view whether one or two MKs are producing these proplatelet extensions. This should be counted as one proplatelet-bearing MK. Images taken with an inverted microscope, 10X objective. Scale Bar, 50 µm.

Figure 3
Figure 3: Abundance of platelets produced in vitro and platelet activation. (A) Human platelets from platelet-rich plasma were used to set the analytical gate using a log scale for forward and side scatter (left panel). The right panel shows cells from MK cultures. Platelets produced in vitro are observed in the analytical gate defined for human platelets. Cells and counting beads are indicated in the figure. Plt, platelet (B) Platelets produced in vitro were stained with anti-CD41 antibody. Human platelets from platelet-rich plasma were used to set the analytical gate using a log scale for forward and side scatter and to compare the profile within the CD41-FITC gate. C-FITC, FITC isotype control (C) Platelet activation following treatment by ADP to a final concentration of 20 µM. Human platelets from platelet-rich plasma were used as control (upper panels). Platelets produced in culture are shown in the lower panels. Binding of PAC1 antibody indicates platelet activation. C-FITC, FITC isotype control.

Divulgaciones

The authors have nothing to disclose.

Materials

Cell Culture Reagents
Recombinant Human TPO Miltenyi Biotec 130-094-013
StemSpan SFEM II Stem Cell Technologies 9605 Serum-free media for CD34+ cells
Flow Cytometry and Cell Staining Reagents
PE Mouse anti-Human CD34 BD Biosciences 340669 Clone 8G12. This can be used for CD34 purity check. Final antibody concentration 1:10 dilution.
PerCP mouse anti-human CD45 BD Biosciences 347464 1:10 dilution
PerCP isotype control BD Biosciences 349044 1:10 dilution
FITC Mouse anti-Human CD41a BD Biosciences 340929 Final antibody concentration 1:5 dilution.
APC Mouse anti-Human CD42b BD Biosciences 551061 This antibody can also be used to detect mature MK (the percentage of positive cells in usually lower than with anti CD42a). Final antibody concentration 1:10 dilution.
Alexa Fluor 647 Mouse anti-Human CD42a AbD Serotec MCA1227A647T Currently distributed by Bio-Rad. Final antibody concentration 1:10 dilution.
Alexa Fluor 647 Mouse Negative Control AbD Serotec MCA928A647 Currently distributed by Bio-Rad. Isotype control antibody
Anti von Willebrand factor rabbit polyclonal Abcam AB6994 1:200 dilution
V450 mouse anti-humna CD41a BD Biosciences 58425 1: 20 dilution
V450 isotype control BD Biosciences 580373 1:20 dilution
PAC1-FITC antibody BD Biosciences 340507 1:10 dilution
Anti CD62p mouse monoclonal Abcam AB6632 1:200 dilution
Alexa Fluor 488 goat anti rabbit IgG Invitrogen A11008 1:100 dilution
Alexa Fluor 594 goat anti mouse IgG Invitrogen A11020 1:100 dilution
Ig Isotype Control cocktail-C BD Biosciences 558659 Isotype control antibody
Propidium iodide Sigma Aldrich P4864
CountBright Absolute Counting Beads Molecular Probes, Invitrogen C36950 Counting beads
Materials
Falcon 5mL round bottom polypropylene FACS tubes, with Snap Cap, Sterile In Vitro technologies 352063
Glass slides Menzel-Glaser J3800AMNZ
Mounting media with DAPI Vector Laboratories H-1200 Antifade mounting medium with DAPI
Equipment
Inverted microscope Leica DMIRB inverted microscope
Fluorescent microscope Zeiss Vert.A1
Cell analyser BD Biosciences FACS Canto II
Cytospin centrifuge ThermoScientific Cytospin 4
Software
Cell analyser software BD Biosciences FACS Diva Software
Single cell analysis software Tree Star FlowJo
Fluorescent microscope software Zeiss Zen 2 blue edition

Tags

Play Video

Citar este artículo
An In Vitro Method for the Differentiation of Megakaryocytes and Platelet Formation. J. Vis. Exp. (Pending Publication), e21532, doi: (2023).

View Video